0	7	Danazol	Danazol	NNP
8	17	decreases	decrease	VBZ
18	31	transcription	transcription	NN
32	34	of	of	IN
35	43	estrogen	estrogen	NN
44	52	receptor	receptor	NN
53	57	gene	gene	NN
58	60	in	in	IN
61	66	human	human	JJ
67	76	monocytes	monocyte	NNS
76	77	.	.	.

79	80	1	1	LS
80	81	.	.	.

82	96	Administration	Administration	NNP
97	99	of	of	IN
100	107	danazol	danazol	NN
108	111	for	for	IN
112	116	over	over	IN
117	120	one	one	CD
121	126	month	month	NN
127	134	reduced	reduce	VBD
135	138	the	the	DT
139	145	levels	level	NNS
146	148	of	of	IN
149	157	estrogen	estrogen	NN
158	166	receptor	receptor	NN
167	168	(	(	(
168	170	ER	ER	NNP
170	171	)	)	)
172	175	and	and	CC
176	179	its	its	PRP$
180	184	mRNA	mrna	NN
185	187	to	to	TO
188	201	approximately	approximately	RB
202	204	50	50	CD
205	208	and	and	CC
209	211	20	20	CD
211	212	%	%	NN
212	213	,	,	,
214	226	respectively	respectively	RB
227	229	in	in	IN
230	239	monocytes	monocyte	NNS
239	240	.	.	.

241	242	2	2	LS
242	243	.	.	.

244	251	Danazol	Danazol	NNP
252	255	did	do	VBD
256	259	not	not	RB
260	265	alter	alter	VB
266	269	the	the	DT
270	281	degradation	degradation	NN
282	286	rate	rate	NN
287	289	of	of	IN
290	292	ER	ER	NNP
293	297	mRNA	mRNA	NNP
298	300	in	in	IN
301	310	monocytes	monocyte	NNS
310	311	.	.	.

312	313	3	3	LS
313	314	.	.	.

315	322	Danazol	Danazol	NNP
323	332	decreased	decrease	VBD
333	336	the	the	DT
337	350	transcription	transcription	NN
351	355	rate	rate	NN
356	358	of	of	IN
359	361	ER	ER	NNP
362	366	gene	gene	NN
367	369	to	to	TO
370	383	approximately	approximately	RB
384	386	50	50	CD
386	387	%	%	NN
388	390	in	in	IN
391	400	monocytes	monocyte	NNS
401	403	in	in	IN
404	405	a	a	DT
406	412	run-on	run-on	JJ
413	418	assay	assay	NN
418	419	.	.	.

420	421	4	4	LS
421	422	.	.	.

423	430	Danazol	Danazol	NNP
431	434	may	may	MD
435	442	release	release	VB
443	451	estrogen	estrogen	NN
452	464	predominance	predominance	NN
465	468	via	via	IN
469	472	the	the	DT
473	482	reduction	reduction	NN
483	485	of	of	IN
486	499	transcription	transcription	NN
500	503	for	for	IN
504	506	ER	ER	NNP
507	511	gene	gene	NN
511	512	,	,	,
513	518	which	which	WDT
519	524	leads	lead	VBZ
525	527	to	to	TO
528	531	the	the	DT
532	541	reduction	reduction	NN
542	544	of	of	IN
545	547	ER	ER	NNP
548	552	mRNA	mRNA	NNP
553	556	and	and	CC
557	559	ER	ER	NNP
560	571	expressions	expression	NNS
572	574	in	in	IN
575	584	monocytes	monocyte	NNS
584	585	.	.	.